World Library  
Flag as Inappropriate
Email this Article

Chlormadinone acetate

Article Id: WHEBN0022949352
Reproduction Date:

Title: Chlormadinone acetate  
Author: World Heritage Encyclopedia
Language: English
Subject: Cyproterone acetate, Delmadinone acetate, Hydroxyflutamide, Zanoterone, 5-Androstenedione
Collection: 5-Alpha-Reductase Inhibitors, Acetate Esters, Antiandrogens, Antigonadotropins, Glucocorticoids, Progestogens, Steroids
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Chlormadinone acetate

Chlormadinone acetate
Systematic (IUPAC) name
(8ξ,10ξ,13ξ,17α)-6-chloro-3,20-dioxopregn-4-en-17-yl acetate
Clinical data
Legal status
  • Prescription only
Routes Oral
Pharmacokinetic data
Half-life 34-38 hours
Identifiers
CAS number
ATC code G03
PubChem
ChemSpider
ChEMBL
Chemical data
Formula C23H29ClO4
Mol. mass 404.92696 g/mol

Chlormadinone acetate (INN, USAN, BAN, JAN; sold under brand names including Clordion, Gestafortin, Lormin, Non-Ovlon, Normenon, Verton, and many others), sometimes abbreviated as CMA, is a steroidal progestin with additional antiandrogen and antigonadotropic (and thus also antiestrogenic) effects.[1][2][3][4] It is used clinically as a hormonal contraceptive, and in part due to its lowering of estrogen levels, but also for improved effectiveness in contraception, chlormadinone is frequently combined with ethinyl estradiol for this purpose.[5] It is the acetate ester of chlormadinone.[1][2]

Synthesis

Chlormadinone acetate synthesis:[6]

See also

References

  1. ^ a b F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 419.  
  2. ^ a b Index Nominum 2000: International Drug Directory. Taylor & Francis US. 2000. p. 215.  
  3. ^ Raudrant D, Rabe T (2003). "Progestogens with antiandrogenic properties". Drugs 63 (5): 463–92.  
  4. ^ Chassard D, Schatz B (2005). "[The antigonadrotropic activity of chlormadinone acetate in reproductive women]". Gynécologie, Obstétrique & Fertilité (in French) 33 (1-2): 29–34.  
  5. ^ Bouchard P (2005). "Chlormadinone acetate (CMA) in oral contraception--a new opportunity". The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception. 10 Suppl 1: 7–11.  
  6. ^ Brückner, K.; Hampel, B.; Johnsen, U. (1961). "Darstellung und Eigenschaften monohalogenierter 3-Keto-Δ4.6-dien-steroide". Chemische Berichte 94 (5): 1225.  


This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.